## MKTX: MarketAxess Holdings, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 1.7% below STRENGTH zone (4.0-10.0%); PEG 2.31 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($163.94)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. MarketAxess Announces Medium-Term Financial Targets1 Increases Stock Repurchase Authorization to $505 million Intends to Effect an Accelerated Stock Repurchase**
- Source: Business Wire | 20251209T123245 | Bullish | Relevance: 99%
-  MarketAxess Holdings Inc. (Nasdaq: MKTX) announced new medium-term financial targets for 2026-2028, aiming for 8-9% average annual total revenue growth and a 75-125 basis points per year increase in operating margin. The company's Board of Directors also authorized an additional $400 million for stock repurchases, bringing the total authorization to $505 million, and plans an Accelerated Stock Repurchase (ASR) of $300 million with JPMorgan Chase Bank. These actions reflect confidence in the company's long-term strategy and commitment to driving stockholder value.

**2. Invesco Ltd. Sells 50,990 Shares of MarketAxess Holdings Inc. $MKTX**
- Source: MarketBeat | 20251208T120845 | Neutral | Relevance: 99%
-  Invesco Ltd. reduced its stake in MarketAxess Holdings Inc. (NASDAQ:MKTX) by 5.6% in the second quarter, selling 50,990 shares and now owning 853,213 shares valued at approximately $190.6 million. This trimming of its position comes as other institutional investors have either increased their holdings or acquired new positions in the financial services provider. Analysts currently have a "Hold" consensus rating for MarketAxess, with diverse price targets and recent downgrades from some firms.

**3. MarketAxess Holdings Inc. $MKTX Shares Sold by Ossiam**
- Source: MarketBeat | 20251209T122945 | Neutral | Relevance: 99%
-  Ossiam significantly reduced its stake in MarketAxess Holdings Inc. by 59.2% in the second quarter, selling 58,000 shares. Meanwhile, other institutional investors like Prudential Financial and Ethic Inc. increased their holdings. MarketAxess reported strong quarterly earnings, surpassing analyst estimates, and declared a quarterly dividend of $0.76 per share.

**4. MarketAxess Announces Stock Repurchase Increase**
- Source: TipRanks | 20251209T130345 | Somewhat-Bullish | Relevance: 99%
- MarketAxess Holdings Inc. (MKTX) announced an increase in its stock repurchase authorization to $505 million, reflecting confidence in its long-term strategy and commitment to stockholder value creation. The company plans an Accelerated Stock Repurchase of $300 million with JPMorgan Chase Bank, funded by cash and borrowings. MKTX is currently rated a Hold by analysts with a $183.00 price target, and Spark, TipRanks’ AI Analyst, considers it a Neutral, citing strong financials but fair valuation and technical resistance.

**5. Burgundy Asset Management Ltd. Has $92.55 Million Stock Position in MarketAxess Holdings Inc. $MKTX**
- Source: MarketBeat | 20251207T101519 | Neutral | Relevance: 98%
-  Burgundy Asset Management Ltd. increased its stake in MarketAxess Holdings Inc. by 2.9% in Q2, bringing its total holding to 414,370 shares valued at $92.55 million. This represents a 1.11% ownership in the financial services provider. MarketAxess reported strong Q3 earnings per share, surpassing analyst estimates, although revenue slightly missed expectations.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Morgan Stanley | $209 | $247 | -15% |
| 2025-11-10 | Barclays | $188 | $186 | +1% |
| 2025-11-10 | Keefe, Bruyette | $198 | $194 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Morgan Stanley | down | Equal-Weight |
| 2025-11-10 | Barclays | main | Equal-Weight |
| 2025-11-10 | Keefe, Bruyette | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (-11.6%)
- Primecap Management : 6.0% (+66.6%)
- FMR, LLC: 5.8% (-8.1%)
- Van Eck Associates C: 5.2% (+6.5%)
- Blackrock Inc.: 5.0% (-30.2%)

### Key Risks

1. Long-term trend broken: trading 12.5% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +7.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.31 elevated, pricing in significant growth expectations. Forward P/E 21.3x attractive for 39% earnings growth. Quality metrics strong (ROA 11%, margin 26%). Balance sheet: strong liquidity (2.5x), low leverage (D/E 0.45). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.5B |
| Beta | 0.99 |
| 52W Range | $156.17 - $244.05 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.31 |
| Forward P/E | 21.3 |
| Current P/E | 29.6 |
| YoY Growth | 39.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -5.7% to 1.7% (+7.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.3pp (needs >4.0% for momentum thesis). MRS_5 at 3.8% confirms short-term momentum alignment. AM_20 at 4.0% shows strong absolute momentum above own 20MA. Below SMA200 (0.88x), long-term trend not supportive. MACD histogram positive (0.88), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.72% (CS: 69) | Neutral |
| RSI_14 | 60.1 | Neutral |
| MACD Histogram | 0.88 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 0.875x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $173.16
- **Stop Loss:** $163.94 (5.3% risk)
- **Target:** $182.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 54
- **Position Value:** $9,350.64
- **Portfolio %:** 9.35%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-05 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.68 | $1.84 | +9.5% |
| 2025Q2 | $1.96 | $1.91 | -2.6% |
| 2025Q1 | $1.81 | $0.40 | -77.9% |
| 2024Q4 | $1.68 | $1.73 | +3.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*